Dolphin Medical Services Ltd
₹6.31
(4.83%)
Sun, 18 Oct 2026, 06:44 pm
Health Services
Medical/Nursing Services
24.5KDolphin Medical Services Ratios
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 21.65 | 0 | 28900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price to book ratio | 0.16 | 0.28 | 0.25 | 0.18 | 0.12 | 0.12 | 0.16 | 0.14 | 0.18 | 0.13 | 0.12 | 0.07 | 0.21 | 0.29 | 0.23 | 0.40 | 0.34 |
| Price to sales ratio | 1.03 | 1.47 | 1.07 | 0.79 | 1.46 | 1.67 | 5.29 | 3.12 | 6.45 | 10.35 | 22.64 | 4.14 | 4.76 | 5.78 | 3.88 | 5.94 | 4.34 |
| Price to cash flow ratio | 0 | 5.90 | 8.57 | 3.40 | 63.84 | 114.08 | 43.59 | 0 | 0 | 0 | 73.30 | 0 | 8.26 | 0 | 0 | 0 | 0 |
| Enterprise value | 7.68Cr | 11.8Cr | 11.31Cr | 10.69Cr | 9.95Cr | 9.76Cr | 10.11Cr | 9.92Cr | 10.46Cr | 9.79Cr | 7.58Cr | 7.12Cr | 2.82Cr | 3.68Cr | 3.11Cr | 4.82Cr | 4.23Cr |
| Enterprise value to EBITDA ratio | 13.81 | 10.72 | 9.12 | 11.73 | 0 | 0 | 0 | 57.28 | 569.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 655.59 |
| Debt to equity ratio | 0.31 | 0.39 | 0.39 | 0.47 | 0.58 | 0.61 | 0.63 | 0.64 | 0.66 | 0.67 | 0.56 | 0.59 | 0.06 | 0.07 | 0.07 | 0.08 | 0.09 |
| Return on equity % | 0 | -0.51 | 0.01 | -8.78 | -12.99 | -6.26 | -4.39 | -0.36 | -2.12 | -2.41 | -8.60 | -3.50 | -2.93 | -1.80 | -1.22 | -1.03 | -0.34 |
Dolphin Medical Services Ltd Ratios
The Dolphin Medical Services Ltd Ratios page provides a complete fundamental analysis of Dolphin Medical Services Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Dolphin Medical Services Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Dolphin Medical Services Ltd (NSE: , BSE: 526504) is currently trading at ₹6.31, with a market capitalization of ₹9.53Cr. As a major player in the Health services sector and Medical/Nursing services industry, Dolphin Medical Services Ltd remains a key stock for fundamental analysis using Dolphin Medical Services Ltd Ratios.
Dolphin Medical Services Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Dolphin Medical Services Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Dolphin Medical Services Ltd Ratios.
Historically, the Dolphin Medical Services Ltd P/E ratio has shown strong fluctuations:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The decline in Dolphin Medical Services Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Dolphin Medical Services Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.34.
Historical P/B trend:
- 2024: 0.34
- 2023: 0.40
- 2022: 0.23
- 2021: 0.29
Dolphin Medical Services Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Dolphin Medical Services Ltd P/S ratio currently stands at 4.34, an important part of Dolphin Medical Services Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 4.34
- 2023: 5.94
- 2022: 3.88
- 2021: 5.78
A stable or declining Dolphin Medical Services Ltd P/S ratio indicates cautious market sentiment.
Dolphin Medical Services Ltd Price to Cash Flow Ratio (P/CF)
The Dolphin Medical Services Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.
Historical Dolphin Medical Services Ltd Price to Cash Flow Ratio:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 8.26
The declining Dolphin Medical Services Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Dolphin Medical Services Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Dolphin Medical Services Ltd EV currently stands at ₹4.23Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 4.23Cr
- 2023: 4.82Cr
- 2022: 3.11Cr
- 2021: 3.68Cr
Dolphin Medical Services Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Dolphin Medical Services Ltd EV/EBITDA ratio is currently 655.59, a key metric in Dolphin Medical Services Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 655.59
- 2023: 0
- 2022: 0
- 2021: 0
Higher Dolphin Medical Services Ltd EV/EBITDA suggests premium valuation.
Dolphin Medical Services Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Dolphin Medical Services Ltd D/E ratio is currently 0.09, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.09
- 2023: 0.08
- 2022: 0.07
- 2021: 0.07
Dolphin Medical Services Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Dolphin Medical Services Ltd ROE currently stands at -0.34%, showing profitability and capital efficiency.
Historical ROE:
- 2024: -0.34
- 2023: -1.03
- 2022: -1.22
- 2021: -1.80
Declining ROE indicates pressure on profitability.
Dolphin Medical Services Ltd Ratios Analysis Summary
The Dolphin Medical Services Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Dolphin Medical Services Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Dolphin Medical Services Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
